ASTORIA, NY, UNITED STATES, September 21, 2022 /EINPresswire.com/ -- Some skin conditions are not as they appear. One of them is mycosis fungoides, a common cancer ...
Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...
In the last few years, there have been scattered reports linking dupilumab with mycosis fungoides. A recent study from the Journal of the American Academy of Dermatology reported a systematic review ...
The mycosis fungoides market is anticipated to progress steadily, influenced by the relatively small pipeline of emerging therapies. Leading candidates such as Soligenix's HYBRYTE and Innate Pharma's ...
DelveInsight’s, “Mycosis Fungoides Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 6+ pipeline drugs in Mycosis Fungoides pipeline landscape. It covers the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback